MEDICAL MARVELS.

Their latest disruption: Starting in July, the company will sell its first so-called biosimilar drug, Yusimry, an alternative to the immunology drug Humira, one of the bestselling medications of all time, at a cost of $569.27 plus dispensing and shipping fees, vs. $6,922 for a similar dosage of Humira. MORE THAN ONE-THIRD OF AMERICANS, including nearly half of those with annual incomes below $50,000, have skipped taking prescribed drugs because of high prices - something former radiologist Alex Oshmyan-sky witnessed firsthand among his patients, sometimes with devastating health consequences. When Shkreli, a former pharmaceutical executive, raised the price of Dara-prim, a lifesaving drug used to treat parasitic infections, by 5,400 percent from $13.50 a pill to $750 in 2015, Oshmyansky decided he would take on price gouging by the pharmaceutical industry himself by selling off-patent drugs at manufacturing costs. M.G. MAKING MEDICINE MORE AFFORDABLE FOR ALL Alex Oshmyansky & Mark Cuban CO-FOUNDERS, MARK CUBAN COST PLUS DRUG CO. [Extracted from the article]